Streetbeat News

Stock Prices

AMZN

CVNA

DASH

LCID

PDD

QS

RIVN

SBUX

TSLA

UPBD

The article highlights significant options activity in the Consumer Discretionary sector, focusing on large trades by 'whales' in stocks like TSLA, CVNA, LCID, SBUX, QS, RIVN, AMZN, UPBD, PDD, and DASH. These trades could indicate potential short-term price movements.

Portfolio Pulse from Benzinga Insights

July 29, 2024 | 5:35 pm

META

Meta Platforms announced that the Meta Quest V68 software update will begin rolling out today.

Portfolio Pulse from Benzinga Newsdesk

July 29, 2024 | 5:35 pm

EW

Edwards Lifesciences (NYSE:EW) has significantly outperformed the market over the past 20 years, delivering an average annual return of 16.83%. A $100 investment in EW 20 years ago would be worth $2,203.74 today. The article highlights the power of compounded returns over time.

Portfolio Pulse from Benzinga Insights

July 29, 2024 | 5:32 pm

AAPL

AMG

AMZN

ARLP

CNA

MCD

META

MSFT

ON

RVTY

SCHW

SPY

TLT

TSLA

XLE

XLY

Wall Street opened higher on Monday, driven by optimism ahead of major tech earnings and the Federal Reserve's meeting. Tesla rebounded 5% after a bullish note from Morgan Stanley, while oil prices dropped to 7-week lows. Key economic data and earnings reports from major companies like Microsoft, Apple, Meta, and Amazon are expected this week.

Portfolio Pulse from Piero Cingari

July 29, 2024 | 5:31 pm

BTCUSD

DOGEUSD

Elon Musk shared his thoughts on cryptocurrency, expressing a fondness for Dogecoin and acknowledging some merit in Bitcoin. He clarified that he won't be promoting crypto seriously and refuted claims of discussing crypto with Donald Trump. Musk's comments come after the Bitcoin 2024 conference where Trump made bold promises regarding cryptocurrency policies.

Portfolio Pulse from Murtuza Merchant

July 29, 2024 | 5:28 pm

LPTV

Loop Media shares are trading higher following the announcement of a content partnership with Red Bull to launch Red Bull TV channel across all out-of-home venues nationwide.

Portfolio Pulse from Benzinga Newsdesk

July 29, 2024 | 5:23 pm

EXAS

GH

The FDA has approved Guardant Health's Shield blood test for colorectal cancer screening in adults aged 45 and older. Despite the approval, analysts are cautious about its adoption due to several limitations highlighted in the product label. Guardant Health's Shield will compete with Exact Sciences' Cologuard. GH stock rose by 5.42% following the news.

Portfolio Pulse from Vandana Singh

July 29, 2024 | 5:21 pm

BMRC

CGTX

TWOU

Bank of Marin Bancorp (NASDAQ:BMRC) shares fell sharply after reporting worse-than-expected quarterly earnings. Other notable stock movements include 2U, Inc. (NASDAQ:TWOU) climbing 128% and Cognition Therapeutics, Inc. (NASDAQ:CGTX) falling 34%.

Portfolio Pulse from Avi Kapoor

July 29, 2024 | 5:19 pm

MSFT

Microsoft's upcoming earnings report on Tuesday is crucial as it could influence the entire market, especially the technology sector. Traders are closely watching the $432 resistance level. If MSFT fails to break this level, it could signal a market shift and a potential downtrend for the tech sector.

Portfolio Pulse from Mark Putrino

July 29, 2024 | 5:15 pm

GRI

GRI Bio shares are trading lower following the company's announcement to increase the shares of common stock available for sale under its At The Market Offering Agreement with H.C. Wainwright & Co.

Portfolio Pulse from Benzinga Newsdesk

July 29, 2024 | 5:15 pm